Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Chronic Idiopathic Constipation
MedTech
Vibrant passes vibrating constipation pill through FDA review
Fresh off reporting the promising results of a phase 3 study of its constipation relief device, Vibrant Gastro is keeping things moving.
Andrea Park
Sep 1, 2022 10:40am
Vibrating pill for constipation heads to FDA after phase 3 study
May 23, 2022 10:55am
Anji Pharma snags $70M for phase 3 diabetes and mid-stage asset
Sep 28, 2021 6:30am
Valeant wins FDA oral Relistor approval and $1B sales potential
Jul 20, 2016 5:06am